Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […]
The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […] Evolutionary ecology theory offers avenues to anticipate the future behavior of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. […] A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […] A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […] The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, has claimed […] With over 127.8 million cases of coronavirus disease 2019 (COVID-19) already documented, and many more millions that have undoubtedly gone […] The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with […] The heterogeneous coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, […] Nanomedicine is a very powerful tool with the potential to mitigate the burden of disease by providing nanoparticle-based carriers and […]Severe Acute Respiratory
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents
Can universal vaccines and treatments against future SARS-CoV-2 variants be developed?
Researchers develop novel test that screens for SARS-CoV-2 variants of concern
Researchers develop novel test that screens for SARS-CoV-2 variants of concern
Long-COVID-19 is a significant risk in recovered patients post-hospitalization
Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests
Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation
Living with a COVID-19 case brings worse symptoms and stronger antibody response
The role of nanotechnology in the fight against COVID-19